Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Latest Smart Money Sentiment Towards Hannon Armstrong Sustnbl Infrstr Cap Inc (HASI)

Page 1 of 2

The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors endured a turbulent quarter, which certainly propelled them to adjust their equity holdings so as to maintain their desired risk profile. As a result, the relevancy of these public filings and their content is indisputable, as they may reveal numerous high-potential stocks. The following article will discuss the smart money sentiment towards Hannon Armstrong Sustnbl Infrstr Cap Inc (NYSE:HASI).

Hannon Armstrong Sustnbl Infrstr Cap Inc (NYSE:HASI) was in 8 hedge funds’ portfolios at the end of September. HASI shareholders have witnessed a decrease in activity from the world’s largest hedge funds in recent months. There were 9 hedge funds in our database with HASI holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as TriCo Bancshares (NASDAQ:TCBK), Regenxbio Inc (NASDAQ:RGNX), and U.S. Physical Therapy, Inc. (NYSE:USPH) to gather more data points.

Follow Hannon Armstrong Sustainable Infrastructure Capital Inc. (NYSE:HASI)
Trade (NYSE:HASI) Now!

To most stock holders, hedge funds are viewed as worthless, old investment tools of the past. While there are over 8,000 funds with their doors open today, our researchers look at the crème de la crème of this club, around 700 funds. Most estimates calculate that this group of people have their hands on bulk of the hedge fund industry’s total capital, and by keeping track of their finest stock picks, Insider Monkey has unearthed many investment strategies that have historically outrun the market. Insider Monkey’s small-cap hedge fund strategy defeated the S&P 500 index by 12 percentage points per year for a decade in their back tests.

Now, we’re going to analyze the latest action encompassing Hannon Armstrong Sustnbl Infrstr Cap Inc (NYSE:HASI).

What does the smart money think about Hannon Armstrong Sustnbl Infrstr Cap Inc (NYSE:HASI)?

At Q3’s end, a total of 8 of the hedge funds tracked by Insider Monkey held long positions in this stock, a decrease of 11% from one quarter earlier. With the smart money’s capital changing hands, there exists a few key hedge fund managers who were boosting their holdings meaningfully (or had already accumulated large positions).

Of the funds tracked by Insider Monkey, Ardsley Partners, managed by Philip Hempleman, holds the most valuable position in Hannon Armstrong Sustnbl Infrstr Cap Inc (NYSE:HASI). Ardsley Partners has a $21.4 million position in the stock, comprising 5.2% of its 13F portfolio. The second-largest stake is held by Lorem Ipsum Management, led by John Segrich and Michael Molnar, holding a $9.8 million position; 4.5% of its 13F portfolio is allocated to the company. Remaining peers with similar optimism consist of Renaissance Technologies, Jonathan Barrett and Paul Segal’s Luminus Management, and D E Shaw.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!